Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets.
Lixte Biotechnology Holdings stock last closed at $6.14, down 7.39% from the previous day, and has decreased 26.38% in one year. It has underperformed other stocks in the Biotechnology industry by 0.15 percentage points. Lixte Biotechnology Holdings stock is currently +42.13% from its 52-week low of $4.32, and -77.26% from its 52-week high of $27.00.
There are currently 1.67M LIXT shares outstanding. The market cap of LIXT is $10.23M. In the past 24 hours, 16,776 LIXT shares were traded.
You need a brokerage account to access the NASDAQ market and buy LIXT shares.
Based on our experience, eToro is the best brokerage. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro today.
Open eToro AccountNow that you've chosen the best brokerage, you'll need to fill out some personal information so you are able to invest in LIXT today.
Now that you've created your account on a good online stock trading app, your next step is to transfer the money for your investment:
Watch the tutorial below to see the process of transferring money into your investment account.
After you have identified the best place to buy Lixte Biotechnology Holdings stock, it's critical to evaluate their stock prior to investing, so you actually understand the risk and opportunity.
WallStreetZen was created to help everyday investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on LIXT's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge LIXT's true value.
Using relative valuations methods:
You can access more valuation analysis on LIXT's stock here.
Over the last 12 months, executives and large shareholders at LIXT have bought more shares than they have sold.
Der Baan Bastiaan Jeroen Van, Director of LIXT, was the latest LIXT insider to buy. They bought $49,000.00 worth of LIXT stock on Dec 30, 2022.
Research more about who owns LIXT stock here.
No, Lixte Biotechnology Holdings doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two primary options:
Hit the Open Trade button and eToro will execute the order.
If you want additional help with buying stocks on eToro, watch the helpful video below:
Now that you own some shares in LIXT, you'll want to keep up with your investment.
Put LIXT on a watchlist to track your LIXT stock.
To summarize, here are the 6 steps to buy stock in Lixte Biotechnology Holdings:
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep track of your new investment in Lixte Biotechnology Holdings, create a watchlist today.